HIF1A and breast cancer: Based on previous studies, it is also likely that, in hypoxic BC cells with augmented brain-metastatic capacity, HIF-1 has also programmed augmented cancer stem cell and immune evasive properties (37, 39, 89–92), which together are major determinants of the lethal cancer phenotype.